JP2017081972A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017081972A5 JP2017081972A5 JP2017000107A JP2017000107A JP2017081972A5 JP 2017081972 A5 JP2017081972 A5 JP 2017081972A5 JP 2017000107 A JP2017000107 A JP 2017000107A JP 2017000107 A JP2017000107 A JP 2017000107A JP 2017081972 A5 JP2017081972 A5 JP 2017081972A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mesenchymal stem
- stem cells
- pharmaceutically acceptable
- serum albumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (17)
- 精製済み間葉系幹細胞を含む薬学的に許容しうる組成物であって、一つまたはそれを超える間葉系幹細胞集合体を含み、そして該集合体のD90が、約150μm未満である薬学的に許容しうる組成物。
- 前記集合体のD90が、約100μm未満である、請求項1に記載の薬学的に許容しうる組成物。
- 前記集合体のD90が、約50μm未満である、請求項2に記載の薬学的に許容しうる組成物。
- 精製済み間葉系幹細胞の生存能力が、約70%より大である、請求項1に記載の薬学的に許容しうる組成物。
- 精製済み間葉系幹細胞の生存能力が、約80%より大である、請求項4に記載の薬学的に許容しうる組成物。
- 精製済み間葉系幹細胞を含む薬学的に許容しうる組成物であって、約55μg/mL未満の残留ウシ血清アルブミンを含み、そしてここにおいて、間葉系幹細胞が、約18μm〜約30μmのD90を示す薬学的に許容しうる組成物。
- 組成物が、約42μg/mL未満の残留ウシ血清アルブミンを含む、請求項6に記載の組成物。
- 組成物が、約25μg/mL未満の残留ウシ血清アルブミンを含む、請求項7に記載の組成物。
- 組成物が、約13μg/mL未満の残留ウシ血清アルブミンを含む、請求項8に記載の組成物。
- 組成物が、約10μg/mL未満の残留ウシ血清アルブミンを含む、請求項9に記載の組成物。
- 組成物が、約7μg/mL〜約15μg/mLの残留ウシ血清アルブミンを含む、請求項6に記載の組成物。
- 組成物が、約8μg/mL〜約12μg/mLの残留ウシ血清アルブミンを含む、請求項11に記載の組成物。
- 間葉系幹細胞が、約18μm〜約25μmのD90を示す、請求項6に記載の組成物。
- 精製済み間葉系幹細胞の生存能力が、約70%より大である、請求項6に記載の組成物。
- 精製済み間葉系幹細胞の生存能力が、約80%より大である、請求項14に記載の組成物。
- 免疫応答、肺塞栓症、血管収縮、または心臓性ショックの予防または治療に有用な医薬としての、請求項1〜14のいずれか一項に記載の組成物。
- 該予防または治療が、免疫原性の増加およびレシピエントからの間葉系幹細胞のクリアランスまたは排泄の促進を防ぐ、請求項16に記載の組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8889808P | 2008-08-14 | 2008-08-14 | |
US61/088,898 | 2008-08-14 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014224180A Division JP2015071610A (ja) | 2008-08-14 | 2014-11-04 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018036415A Division JP2018109052A (ja) | 2008-08-14 | 2018-03-01 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017081972A JP2017081972A (ja) | 2017-05-18 |
JP2017081972A5 true JP2017081972A5 (ja) | 2017-09-21 |
Family
ID=41669330
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011523195A Active JP6025329B2 (ja) | 2008-08-14 | 2009-08-14 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
JP2014224180A Pending JP2015071610A (ja) | 2008-08-14 | 2014-11-04 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
JP2017000107A Pending JP2017081972A (ja) | 2008-08-14 | 2017-01-04 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
JP2018036415A Pending JP2018109052A (ja) | 2008-08-14 | 2018-03-01 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
JP2020072934A Pending JP2020120671A (ja) | 2008-08-14 | 2020-04-15 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
JP2023000381A Pending JP2023052211A (ja) | 2008-08-14 | 2023-01-05 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011523195A Active JP6025329B2 (ja) | 2008-08-14 | 2009-08-14 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
JP2014224180A Pending JP2015071610A (ja) | 2008-08-14 | 2014-11-04 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018036415A Pending JP2018109052A (ja) | 2008-08-14 | 2018-03-01 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
JP2020072934A Pending JP2020120671A (ja) | 2008-08-14 | 2020-04-15 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
JP2023000381A Pending JP2023052211A (ja) | 2008-08-14 | 2023-01-05 | 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 |
Country Status (14)
Country | Link |
---|---|
US (5) | US8637004B2 (ja) |
EP (2) | EP2318519B1 (ja) |
JP (6) | JP6025329B2 (ja) |
AR (2) | AR073069A1 (ja) |
AU (1) | AU2009281809B2 (ja) |
BR (1) | BRPI0917993B8 (ja) |
CA (1) | CA2733985C (ja) |
DK (1) | DK2318519T3 (ja) |
ES (1) | ES2608974T3 (ja) |
IL (1) | IL211214A0 (ja) |
MX (2) | MX362512B (ja) |
NZ (2) | NZ591146A (ja) |
WO (1) | WO2010019886A1 (ja) |
ZA (1) | ZA201101858B (ja) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007530543A (ja) | 2004-03-22 | 2007-11-01 | オシリス セラピューティクス,インコーポレイテッド | 間葉幹細胞及びその使用法 |
ES2415855T3 (es) | 2006-01-13 | 2013-07-29 | Osiris Therapeutics, Inc. | Células troncales mesenquimatosas que expresan el receptor de TNF |
ES2608974T3 (es) | 2008-08-14 | 2017-04-17 | Mesoblast International Sàrl | Composiciones de células madre mesenquimales purificadas |
CA2734236C (en) | 2008-08-20 | 2020-08-25 | Anthrogenesis Corporation | Improved cell composition and methods of making the same |
US9192695B2 (en) | 2008-11-20 | 2015-11-24 | Allosource | Allografts combined with tissue derived stem cells for bone healing |
US20140286911A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Cell repopulated collagen matrix for soft tissue repair and regeneration |
US8895291B2 (en) | 2010-10-08 | 2014-11-25 | Terumo Bct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
EP3679939A1 (en) | 2010-10-08 | 2020-07-15 | Mesoblast International Sàrl | Enhanced msc preparations |
ITGE20120034A1 (it) * | 2012-03-28 | 2013-09-29 | Carlo Tremolada | Preparato e metodo per la produzione di un preparato comprendente cellule staminali mesenchimali |
JP2013252126A (ja) * | 2012-05-08 | 2013-12-19 | Otsuka Pharmaceut Factory Inc | デキストラン含有肺塞栓形成予防用哺乳動物細胞懸濁液 |
US9617506B2 (en) | 2013-11-16 | 2017-04-11 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
EP3613841B1 (en) | 2014-03-25 | 2022-04-20 | Terumo BCT, Inc. | Passive replacement of media |
CN106715676A (zh) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | 按计划供养 |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
EP3238759B1 (en) | 2016-04-29 | 2019-07-17 | Fenwal, Inc. | System and method for processing, incubating and/or selecting biological cells |
US10449283B2 (en) | 2016-04-29 | 2019-10-22 | Fenwal, Inc. | System and method for selecting and culturing cells |
US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US10274495B2 (en) | 2016-12-21 | 2019-04-30 | Fenwal, Inc. | System and method for separating cells incorporating magnetic separation |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
US11702634B2 (en) | 2017-03-31 | 2023-07-18 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
US20210395693A1 (en) * | 2018-10-26 | 2021-12-23 | Guy MARTI | Method and apparatus for mesenchymal stem cells isolation and purification |
JP2022533949A (ja) * | 2019-05-15 | 2022-07-27 | ステムサイト インコーポレーテッド | 高濃度細胞のパッケージングおよび輸送 |
WO2021144995A1 (ja) * | 2020-01-16 | 2021-07-22 | PuREC株式会社 | 高純度間葉系幹細胞 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5034135A (en) * | 1982-12-13 | 1991-07-23 | William F. McLaughlin | Blood fractionation system and method |
US4803075A (en) * | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
WO1988001193A1 (en) * | 1986-08-11 | 1988-02-25 | Hemascience Laboratories, Inc. | Blood cell washing systems and methods |
US5536475A (en) | 1988-10-11 | 1996-07-16 | Baxter International Inc. | Apparatus for magnetic cell separation |
US5226914A (en) * | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5837539A (en) * | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US5234608A (en) * | 1990-12-11 | 1993-08-10 | Baxter International Inc. | Systems and methods for processing cellular rich suspensions |
CA2192103C (en) * | 1994-06-06 | 2002-02-05 | Arnold I. Caplan | Biomatrix for tissue regeneration |
US5707996A (en) * | 1995-11-06 | 1998-01-13 | Macleod Pharmaceuticals, Inc. | Pharmaceutical solution and methods for preparation thereof |
EP0906415B1 (en) * | 1996-04-19 | 2009-08-19 | Osiris Therapeutics, Inc. | Regeneration and augmentation of bone using mesenchymal stem cells |
US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
DK1007631T4 (da) * | 1997-07-14 | 2009-04-27 | Osiris Therapeutics Inc | Hjertemuskelregeneration ved anvendelse af mesenkymale stamceller |
US6251295B1 (en) * | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
US6328960B1 (en) | 1998-03-18 | 2001-12-11 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
FR2787463B1 (fr) | 1998-12-21 | 2001-03-30 | Neurotech | Preparation de cellules de mammifere eventuellement transfectees avec un gene codant pour une substance active et les compositions les contenant |
JP2002325572A (ja) * | 2000-12-25 | 2002-11-12 | Univ Osaka | 外来物質の導入方法 |
US20030054331A1 (en) | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
US8105580B2 (en) * | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
US20050008626A1 (en) | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
US20050095228A1 (en) * | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
EP2305276A3 (en) * | 2001-12-07 | 2011-09-21 | Cytori Therapeutics, Inc. | Processed lipoaspirate cells for use in therapy |
US20050048036A1 (en) * | 2001-12-07 | 2005-03-03 | Hedrick Marc H. | Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues |
US9597395B2 (en) * | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
US7585670B2 (en) * | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
US7514075B2 (en) * | 2001-12-07 | 2009-04-07 | Cytori Therapeutics, Inc. | Systems and methods for separating and concentrating adipose derived stem cells from tissue |
US8404229B2 (en) * | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
ZA200404101B (en) | 2003-05-26 | 2005-03-07 | Reliance Life Sciences Pvt Ltd | In vitro culture of Mesenchymal Stem Cells (MSC) and a process for the preparation thereof for therapeutic use. |
JP2007524396A (ja) | 2003-06-25 | 2007-08-30 | サイトリ セラピューティクス インコーポレイテッド | 組織から再生細胞を分離して濃縮するためのシステム及び方法 |
JP2007530543A (ja) * | 2004-03-22 | 2007-11-01 | オシリス セラピューティクス,インコーポレイテッド | 間葉幹細胞及びその使用法 |
JP3828905B2 (ja) * | 2004-08-05 | 2006-10-04 | 株式会社R&Dセルサイエンス・オプショナルメディコ | 局所麻酔薬を含有する細胞凝集抑制剤 |
US8512724B2 (en) * | 2005-06-10 | 2013-08-20 | The Board Of Regents Of The University Of Texas System | Antiseptic compositions |
WO2008020815A1 (en) | 2006-08-15 | 2008-02-21 | Agency For Science, Technology And Research | Mesenchymal stem cell conditioned medium |
US20070128174A1 (en) | 2005-09-21 | 2007-06-07 | Kleinsek Donald A | Methods and compositions for organ and tissue functionality |
US7888119B2 (en) * | 2005-10-14 | 2011-02-15 | University Of Central Florida Research Foundation, Inc. | Tissue substitutes comprising stem cells and reduced ceria |
US20070253931A1 (en) * | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
WO2007089798A2 (en) * | 2006-01-30 | 2007-08-09 | University Of Virginia Patent Foundation | Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof |
US8679809B2 (en) | 2006-05-19 | 2014-03-25 | The University Of Hong Kong | Cell-matrix microspheres, methods for preparation and applications |
DE602007012290D1 (de) * | 2006-11-03 | 2011-03-10 | Aastrom Biosciences Inc | Mischzell-populationen für die gewebereparatur und trenntechnik für die zellaufbereitung |
JP2008139106A (ja) * | 2006-11-30 | 2008-06-19 | Sysmex Corp | 骨髄穿刺液収容具及び骨髄穿刺液濾過方法 |
KR20090086260A (ko) | 2006-12-07 | 2009-08-11 | 테바 파마슈티컬 인더스트리즈 리미티드 | 미손상 골수 또는 미손상 제대 조직으로부터 조직 전구체 세포 및 성숙 조직 세포를 형성 및 증식시키는 방법 |
US20110262402A1 (en) | 2007-09-07 | 2011-10-27 | Masahiko Kuroda | Therapeutic and prophylactic agents for arthritis |
US8465733B2 (en) | 2007-11-02 | 2013-06-18 | Jcr Pharmaceuticals Co., Ltd. | Pharmaceutical composition containing human mesenchymal stem cell |
ES2608974T3 (es) | 2008-08-14 | 2017-04-17 | Mesoblast International Sàrl | Composiciones de células madre mesenquimales purificadas |
US8217128B2 (en) | 2008-09-04 | 2012-07-10 | Amyris, Inc. | Farnesene interpolymers |
-
2009
- 2009-08-14 ES ES09807366.1T patent/ES2608974T3/es active Active
- 2009-08-14 NZ NZ591146A patent/NZ591146A/xx unknown
- 2009-08-14 BR BRPI0917993A patent/BRPI0917993B8/pt active IP Right Grant
- 2009-08-14 MX MX2014008542A patent/MX362512B/es unknown
- 2009-08-14 NZ NZ602248A patent/NZ602248A/en unknown
- 2009-08-14 WO PCT/US2009/053891 patent/WO2010019886A1/en active Application Filing
- 2009-08-14 AU AU2009281809A patent/AU2009281809B2/en active Active
- 2009-08-14 MX MX2011001730A patent/MX2011001730A/es active IP Right Grant
- 2009-08-14 JP JP2011523195A patent/JP6025329B2/ja active Active
- 2009-08-14 DK DK09807366.1T patent/DK2318519T3/en active
- 2009-08-14 EP EP09807366.1A patent/EP2318519B1/en not_active Revoked
- 2009-08-14 US US12/541,282 patent/US8637004B2/en active Active
- 2009-08-14 CA CA2733985A patent/CA2733985C/en active Active
- 2009-08-14 EP EP16189444.9A patent/EP3124601A1/en active Pending
- 2009-08-18 AR ARP090103159A patent/AR073069A1/es not_active Application Discontinuation
-
2011
- 2011-02-14 IL IL211214A patent/IL211214A0/en active IP Right Grant
- 2011-03-10 ZA ZA2011/01858A patent/ZA201101858B/en unknown
-
2013
- 2013-12-16 US US14/107,031 patent/US20140105872A1/en not_active Abandoned
-
2014
- 2014-11-04 JP JP2014224180A patent/JP2015071610A/ja active Pending
-
2017
- 2017-01-04 JP JP2017000107A patent/JP2017081972A/ja active Pending
- 2017-05-23 US US15/602,848 patent/US20180008642A1/en not_active Abandoned
-
2018
- 2018-03-01 JP JP2018036415A patent/JP2018109052A/ja active Pending
-
2019
- 2019-11-25 US US16/694,382 patent/US20200197444A1/en not_active Abandoned
-
2020
- 2020-04-15 JP JP2020072934A patent/JP2020120671A/ja active Pending
- 2020-05-05 AR ARP200101271A patent/AR123811A2/es unknown
-
2022
- 2022-09-23 US US17/934,852 patent/US20230089901A1/en active Pending
-
2023
- 2023-01-05 JP JP2023000381A patent/JP2023052211A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018109052A5 (ja) | ||
JP2017081972A5 (ja) | ||
JP2018193377A5 (ja) | ||
JP2016512248A5 (ja) | ||
JP2017525671A5 (ja) | ||
JP2015517489A5 (ja) | ||
JP2018520997A5 (ja) | ||
JP2015078230A5 (ja) | ||
PE20130574A1 (es) | Nuevas formas de dosificacion de liberacion modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa | |
JP2014507482A5 (ja) | ||
JP2015057436A5 (ja) | ||
WO2015120110A3 (en) | Novel pharmaceutical formulations | |
NZ591146A (en) | Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills | |
RU2012125254A (ru) | Составы антитела | |
NZ722952A (en) | Inhalable pharmaceutical compositions | |
Kim et al. | The therapeutic effects of optimal dose of mesenchymal stem cells in a murine model of an elastase induced-emphysema | |
JP2016534142A5 (ja) | ||
MA33374B1 (fr) | Composition de surfactant reconstitué améliorée contenant des analogues de la protéine b du surfactant (sp-b) et de la protéine c du surfactant (sp-c) | |
JP2014508138A5 (ja) | ||
JP2008501316A5 (ja) | ||
JP2013236633A5 (ja) | ||
JP2014527040A5 (ja) | ||
JP2016507526A5 (ja) | ||
JP2011528897A5 (ja) | ||
RU2015139758A (ru) | Хиназолины в качестве ингибиторов киназы |